Charcot-Marie-Tooth Disease

Foot & Ankle Specialist

Volumn 1, Issue 6, 2008, Pages 350-354

  Casasnovas, Carlos ^a   Cano, Luis Miguel ^a   Albertí, Antonia ^a   Céspedes, Maria ^b   Rigo, Gillem ^c  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c NONE

Author keywords

Charcot disease; Charcot Marie Tooth; CMT; hereditary neuropathy; HMSN

Indexed keywords

GENETIC PREDISPOSITION; GENETICS; HEALTH; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; INCIDENCE; ORTHOTICS; PROGNOSIS; REVIEW; UTILIZATION REVIEW;

CHARCOT-MARIE-TOOTH DISEASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; ORTHOTIC DEVICES; PROGNOSIS; WORLD HEALTH;

EID: 70449701919     PISSN: 19386400     EISSN: None     Source Type: Journal    
DOI: 10.1177/1938640008326247     Document Type: Review

References (27)

1. Berciano J., Combarros O. Hereditary neuropathies. Curr Opin Neurol. 2003; 16: 613-622.
2. Emery AE Population frequencies of inherited neuromuscular diseases: a world survey. Neuromuscul Disord. 1991; 1: 19-29.
3. Dick PJ, Chance P., Lebo R., et al. Hereditary motor and sensory neuropaties. In: Dick PJ, ed. Peripheral Neuropathy. 3rd ed. Philadelphia: W. B. Saunders; 1993: 1094-1136.
4. Sevilla T., Vilchez JJ Diferentes fenotipos del síndrome de Charcot-Marie-Tooth causados por mutaciones del mismo gen: ¿siguen siendo útiles los criterios de clasificación clásicos? Neurología. 2004; 19: 264-271.
5. Berciano J., Combarros O., Calleja J., et al. The application of nerve conduction and clinical studies to genetic counseling in hereditary motor and sensory neuropathy type I. Muscle Nerve. 1989; 12: 302-306.
6. Street VA, Meekins G., Lipe HP, et al. Charcot-Marie-Tooth neuropathy: clinical phenotypes of four novel mutations in the MPZ and Cx 32 genes. Neuromuscul Disord. 2002; 12(7-8):643-650.
7. Kurihara S., Adachi Y., Wada K., Awaki E., Harada H., Nakashima K. An epidemiological genetic study of Charcot-Marie-Tooth disease in western Japan. Neuroepidemiology. 2002; 21: 246-250.
8. Hattori N., Yamamoto M., Yoshihara T., et al. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients. Brain. 2003;126(pt 1):134-151.
9. Chung KW, Kim SB, Park KD, et al. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations. Brain. 2006; 129(pt 8):2103-2118.
10. Lupski JR, de Oca-Luna RM, Slaugenhaupt S., et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell. 1991; 66: 219-232.
11. Cuesta A., Pedrola L., Sevilla T., et al. The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease. Nat Genet. 2002; 30: 22-25.
12. Züchner S., Mersiyanova IV, Muglia M., et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet. 2004; 36: 449-451.
13. Sołtysińska E., Kabzińska D., Kochański A. Mutations in the mitofusin 2 gene are the most common cause of Charcot-Marie-Tooth type 2 disease. Neurol Neurochir Pol. 2007; 41: 350-354.
14. Amiott EA, Lott P., Soto J., et al. Mitochondrial fusion and function in Charcot-Marie-Tooth type 2A patient fibroblasts with mitofusin 2 mutations. Exp Neurol. 2008; 211: 115-127.
15. Ishihara N., Eura Y., Mihara K. Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity. J Cell Sci. 2004; 117(pt 26):6535-6546.
16. Züchner S., Vance JM Molecular genetics of autosomal-dominant axonal Charcot-Marie-Tooth disease. Neuromol Med. 2006; 8 (1-2):63-74.
17. Verhoeven K., Claeys KG, Züchner S., et al. MFN2 mutation distribution and genotype/ phenotype correlation in Charcot-Marie-Tooth type 2. Brain. 2006; 129(pt 8):2093-2102.
18. Züchner S., De Jonghe P., Jordanova A., et al. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Ann Neurol. 2006; 59: 276-281.
19. Sevilla T., Cuesta A., Chumillas MJ, et al. Clinical, electrophysiological and morphological findings of Charcot-Marie-Tooth neuropathy with vocal cord palsy and mutations in the GDAP1 gene. Brain. 2003; 126(pt 9):2023-2033.
20. Casasnovas C., Banchs I., Corral J., et al. Clinical and molecular analysis of X-linked Charcot-Marie-Tooth disease type 1 in Spanish population. Clin Genet. 2006; 70: 516-523.
21. Taylor RA, Simon EM, Marks HG, et al. The CNS phenotype of X-linked Charcot-Marie-Tooth disease: more than a peripheral problem. Neurology. 2003;61: 1475-1478.
22. Ramiro J., Alcántara E., Forner A., et al. Guia de recomendaciones para el diseño de calzado. Ed. Sociedad Estatal para el desarrollo de diseño industrial. Valencia, Spain: Instituto de Biomecánica de Valencia, IMPIVA; 1995.
23. Levy-Benasuly A., Cortés-Barragán J. Ortopodología y aparato locomotor. Barcelona, Spain: Masson; 2003.
24. Olney B. Treatment of the cavus foot: deformity in the pediatric patient with Charcot-Marie-Tooth. Foot Ankle Clin. 2000; 5: 305-315.
25. Holmes JR, Hansen ST Jr. Foot and ankle manifestations of Charcot-Marie-Tooth disease. Foot Ankle. 1993; 14: 476-486.
26. Sammarco GJ, Taylor R. Cavovarus foot treated with combined calcaneus and metatarsal osteotomies. Foot Ankle Int. 2001; 22: 19-30.
27. Giza E., Hyer CF, Sella EJ, et al. Charcot neuroarthropathy. Foot Ankle Specialist. 2008; 1: 243-246.